Penn Makes Third Big Biotech Bet, Helping to Raise $53M for Carisma

Cancer-fighting biotech company Carisma Therapeutics Inc. is the latest addition to Penn’s recently-announced investment plan. Roy Rosin, CIO at Penn Medicine, said, “Penn’s commitment is pretty exciting for this region.”

・ From Philadelphia Inquirer